These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

905 related articles for article (PubMed ID: 30342478)

  • 1. Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy.
    Pant T; Dhanasekaran A; Fang J; Bai X; Bosnjak ZJ; Liang M; Ge ZD
    BMC Cardiovasc Disord; 2018 Oct; 18(1):197. PubMed ID: 30342478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and analysis of a lncRNA‑miRNA‑mRNA network based on competitive endogenous RNA reveals functional lncRNAs in diabetic cardiomyopathy.
    Chen K; Ma Y; Wu S; Zhuang Y; Liu X; Lv L; Zhang G
    Mol Med Rep; 2019 Aug; 20(2):1393-1403. PubMed ID: 31173240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 attenuates high glucose-induced cardiomyocyte apoptosis via regulation of miR-181a-5p.
    Cheng Y; Li J; Wang C; Yang H; Wang Y; Zhan T; Guo S; Liang J; Bai Y; Yu J; Liu G
    Exp Anim; 2020 Jan; 69(1):34-44. PubMed ID: 31353329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics.
    Jakubik D; Fitas A; Eyileten C; Jarosz-Popek J; Nowak A; Czajka P; Wicik Z; Sourij H; Siller-Matula JM; De Rosa S; Postula M
    Cardiovasc Diabetol; 2021 Feb; 20(1):55. PubMed ID: 33639953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA Crnde attenuates cardiac fibrosis via Smad3-Crnde negative feedback in diabetic cardiomyopathy.
    Zheng D; Zhang Y; Hu Y; Guan J; Xu L; Xiao W; Zhong Q; Ren C; Lu J; Liang J; Hou J
    FEBS J; 2019 May; 286(9):1645-1655. PubMed ID: 30748104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNAs: A new player in the prevention and treatment of diabetic cardiomyopathy?
    Ma C; Luo H; Liu B; Li F; Tschöpe C; Fa X
    Diabetes Metab Res Rev; 2018 Nov; 34(8):e3056. PubMed ID: 30160026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA and mRNA expression characteristic and bioinformatic analysis in myocardium of diabetic cardiomyopathy mice.
    Zhao M; Wang T; Cai X; Li G; Li N; Zhou H
    BMC Genomics; 2024 Mar; 25(1):312. PubMed ID: 38532337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNAs and miRs as epigenetic signatures in diabetic cardiac fibrosis: new advances and perspectives.
    Tao H; Song ZY; Ding XS; Yang JJ; Shi KH; Li J
    Endocrine; 2018 Nov; 62(2):281-291. PubMed ID: 30054866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy.
    Zhou X; Zhang W; Jin M; Chen J; Xu W; Kong X
    Cell Death Dis; 2017 Jul; 8(7):e2929. PubMed ID: 28703801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNAs: From Clinical Genetics to Therapeutic Targets?
    Boon RA; Jaé N; Holdt L; Dimmeler S
    J Am Coll Cardiol; 2016 Mar; 67(10):1214-1226. PubMed ID: 26965544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Non-coding RNA in Diabetic Cardiomyopathy.
    Xia L; Song M
    Adv Exp Med Biol; 2020; 1229():181-195. PubMed ID: 32285412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of non-coding RNA in diabetic cardiomyopathy.
    Yao X; Huang X; Chen J; Lin W; Tian J
    Cardiovasc Diabetol; 2024 Jun; 23(1):227. PubMed ID: 38951895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of LncRNA MIAT in Diabetic Complications.
    Wang L; Wang H; Luo Y; Wu W; Gui Y; Zhao J; Xiong R; Li X; Yuan D; Yuan C
    Curr Med Chem; 2024; 31(13):1716-1725. PubMed ID: 37711129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and analysis of circulating long non-coding RNAs with high significance in diabetic cardiomyopathy.
    Pant T; Dhanasekaran A; Zhao M; Thorp EB; Forbess JM; Bosnjak ZJ; Benjamin IJ; Ge ZD
    Sci Rep; 2021 Jan; 11(1):2571. PubMed ID: 33510471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide differential expression profiling of lncRNAs and mRNAs associated with early diabetic cardiomyopathy.
    Pant T; Dhanasekaran A; Bai X; Zhao M; Thorp EB; Forbess JM; Bosnjak ZJ; Ge ZD
    Sci Rep; 2019 Oct; 9(1):15345. PubMed ID: 31653946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of long noncoding RNA MALAT1 in the pathogenesis of diabetic cardiomyopathy.
    Zhang M; Gu H; Chen J; Zhou X
    Int J Cardiol; 2016 Jan; 202():753-5. PubMed ID: 26476026
    [No Abstract]   [Full Text] [Related]  

  • 17. RNA-Seq analysis and functional characterization revealed lncRNA NONRATT007560.2 regulated cardiomyocytes oxidative stress and apoptosis induced by high glucose.
    Yu M; Shan X; Liu Y; Zhu J; Cao Q; Yang F; Liu Y; Wang G; Zhao X
    J Cell Biochem; 2019 Oct; 120(10):18278-18287. PubMed ID: 31144399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy.
    Li X; Wang H; Yao B; Xu W; Chen J; Zhou X
    Sci Rep; 2016 Oct; 6():36340. PubMed ID: 27796346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological Functions and Clinical Prospects of Extracellular Non-Coding RNAs in Diabetic Cardiomyopathy: an Updated Review.
    Yin Z; Chen C
    J Cardiovasc Transl Res; 2022 Jun; 15(3):469-476. PubMed ID: 35175553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy.
    Yang F; Qin Y; Wang Y; Li A; Lv J; Sun X; Che H; Han T; Meng S; Bai Y; Wang L
    Cell Physiol Biochem; 2018; 50(4):1230-1244. PubMed ID: 30355944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.